Adjuvant chemotherapy for residual disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)

被引：3
|
作者：
Harshman, Lauren Christine
Werner, Lillian
Wong, Yu-Ning
Yu, Evan Y.
Alva, Ajjai Shivaram
Crabb, Simon J.
Powles, Thomas
Rosenberg, Jonathan E.
Baniel, Jack
Vaishampayan, Ulka N.
Berthold, Dominik R.
Ladoire, Sylvain
Hussain, Syed A.
Milowsky, Matthew I.
Agarwal, Neeraj
Necchi, Andrea
Pal, Sumanta Kumar
Recine, Federica
Bellmunt, Joaquim
Galsky, Matt D.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[4] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[5] Univ Southampton, Southampton, Hants, England
[6] Barts Hlth, Barts Canc Inst, London, England
[7] Royal Free NHS Trust, London, England
[8] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[9] Rabin Med Ctr, Petah Tivka, Israel
[10] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[11] CHU Vaudois, Lausanne, Switzerland
[12] Georges Francois Leclerc Canc Ctr, Dijon, France
[13] Univ Liverpool, Clatterbridge Canc Ctr, Liverpool L69 3BX, Merseyside, England
[14] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[15] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[16] Ist Nazl Tumori Milan, Milan, MI, Italy
[17] City Hope Natl Med Ctr, Duarte, CA USA
[18] San Camillo Forlanini Hosp, Rome, Italy
[19] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[20] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4524
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
    Harshman, L.
    Werner, L.
    Wong, Y. N.
    Yu, E.
    Alva, A.
    Crabb, S.
    Powles, T.
    Rosenberg, J.
    Baniel, J.
    Vaishampayan, U.
    Berthold, D.
    Ladoire, S.
    Hussain, S.
    Milowsky, M.
    Agarwal, N.
    Necchi, A.
    Pal, S.
    Recine, F.
    Bellmunt, J.
    Galsky, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S518 - S518
  • [2] Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    Karaoglu, Aziz
    Oflazoglu, Utku
    Demir, Necla
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (01): : 58 - 63
  • [3] Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers
    Chanza, Nieves Martinez
    Werner, Lillian
    Plimack, Elizabeth
    Yu, Evan Y.
    Alva, Ajjai S.
    Crabb, Simon J.
    Powles, Thomas
    Rosenberg, Jonathan E.
    Baniel, Jack
    Vaishampayan, Ulka N.
    Berthold, Dominik R.
    Ladoire, Sylvain
    Hussain, Syed A.
    Milowsky, Matthew, I
    Agarwal, Neeraj
    Necchi, Andrea
    Pal, Sumanta K.
    Sternberg, Cora N.
    Bellmunt, Joaquim
    Galsky, Matthew D.
    Harshman, Lauren C.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 671 - 679
  • [4] Adjuvant Treatment of Residual Disease Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle Invasive Bladder Cancer
    Krebs, Markus
    Sokolakis, Ioannis
    Seiler, Roland
    Daneshmand, Siamak
    Grivas, Petros
    Gakis, Georgios
    BLADDER CANCER, 2020, 6 (04) : 525 - 535
  • [5] THE ROLE OF NEOADJUVANT CHEMOTHERAPY AS COMPARED TO ADJUVANT CHEMOTHERAPY IN EARLY STAGE, MUSCLE INVASIVE UROTHELIAL TUMOURS
    Chay, Wen Yee
    ANNALS OF ONCOLOGY, 2009, 20 : 29 - 29
  • [6] Radiologic response (RR) by MRI in patients (pts) with muscle-invasive urothelial cancer (MIUC) undergoing neoadjuvant chemotherapy
    Qu, Angela Q.
    Choueiri, Toni K.
    Jacobus, Susanna J.
    Rosenberg, Jonathan E.
    Ramaiya, Nikhil H.
    Krajewski, Katherine Maragaret
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [8] THE EFFECT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH ADVERSE PATHOLOGY AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Parker, William
    Habermann, Elizabeth
    Day, Courtney
    Zaid, Harras
    Frank, Igor
    Thompson, R. Houston
    Tollefson, Matthew
    Boorjian, Stephen
    Pagliaro, Lance
    Karnes, R. Jeffrey
    JOURNAL OF UROLOGY, 2017, 197 (04): : E432 - E432
  • [9] The effect of adjuvant chemotherapy for patients with adverse pathology after neoadjuvant chemotherapy for muscle invasive bladder cancer.
    Parker, William P.
    Haberman, Elizabeth B.
    Day, Courtney N.
    Zaid, Harras B.
    Frank, Igor
    Thompson, Robert Houston
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [10] Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    McFerrin, Coleman
    Davaro, Facundo
    May, Allison
    Raza, Syed
    Siddiqui, Sameer
    Hamilton, Zachary
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (06) : 565 - 572
12345